Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Plasma carboxypeptidases as regulators of the plasminogen system.
A Redlitz, … , D L Eaton, E F Plow
A Redlitz, … , D L Eaton, E F Plow
Published November 1, 1995
Citation Information: J Clin Invest. 1995;96(5):2534-2538. https://doi.org/10.1172/JCI118315.
View: Text | PDF
Research Article Article has an altmetric score of 10

Plasma carboxypeptidases as regulators of the plasminogen system.

  • Text
  • PDF
Abstract

Authors

A Redlitz, A K Tan, D L Eaton, E F Plow

×

Total citations by year

Year: 2025 2024 2023 2021 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 2 2 1 2 1 1 2 4 3 4 4 9 5 7 6 8 14 7 12 10 12 12 12 9 6 5 7 5 1 1 174
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2012 (9)

Title and authors Publication Year
Natural and Engineered Plasmin Inhibitors: Applications and Design Strategies
JE Swedberg, JM Harris
ChemBioChem 2012
Arginine and lysine as products of basic carboxypeptidase activity associated with fibrinolysis
AA Zhloba, TF Subbotina, DS Lupan, VA Bogova, OA Kusheleva
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2012
Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA
H Sejima, K Mori, Y Ariumi, M Ikeda, N Kato
Virus Research 2012
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis
T Sasaki, N Yoshimoto, K Sugimoto, K Takada, N Murayama, H Yamazaki, K Yamamoto, H Ishii
Thrombosis Research 2012
Dietary zinc depletion and repletion affects plasma proteins: an analysis of the plasma proteome
A Grider, K Wickwire, E Ho, CS Chung, J King
BioMetals 2012
Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stability:
Y Masuda, D Saotome, K Takada, K Sugimoto, T Sasaki, H Ishii
Thrombosis and Haemostasis 2012
Fibrinolytic system in preeclampsia
MB Pinheiro, KB Gomes, LM Dusse
Clinica Chimica Acta 2012
Alternative Mechanism of Aspirin in Anti-Thrombotic Therapy: Inhibition of Thrombin Activatable Fibrinolysis Inhibitor
SS An, RS Greenfield
Bulletin of the Korean Chemical Society 2012
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
M Eser, M Kement, S Balin, C Coskun, U Kefeli, M Gumus, YE Altuntas, N Kurt, A Mayadagli
World journal of surgical oncology 2012

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 3 patents
Referenced in 2 Wikipedia pages
25 readers on Mendeley
See more details